Yun C. He

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.

Journal: Journal of translational internal medicine

Published: August 27, 2026

All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia.

All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia.

Journal: NEJM evidence

Published: July 28, 2026

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Journal: Haematologica

Published: June 16, 2026

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Journal: Bone marrow transplantation

Published: February 23, 2026

Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis.

Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis.

Journal: Annals of hematology

Published: February 13, 2026

Conditioning dose adjustment in obese adult patients with severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: a propensity score-matched analysis.

Conditioning dose adjustment in obese adult patients with severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: a propensity score-matched analysis.

Journal: Bone marrow transplantation

Published: February 09, 2026

Acceptance of AI-assisted English language learning tools in higher education: psychological correlates across disciplinary and proficiency groups.

Acceptance of AI-assisted English language learning tools in higher education: psychological correlates across disciplinary and proficiency groups.

Journal: Frontiers in psychology

Published: February 07, 2026

Unmasking the link: pulmonary embolism risk and outcomes in adults with immune thrombocytopenia.

Unmasking the link: pulmonary embolism risk and outcomes in adults with immune thrombocytopenia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 15, 2025

Risk Factors and Outcomes of Pneumocystis jirovecii Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy: A 10-Yr Cohort Study.

Risk Factors and Outcomes of Pneumocystis jirovecii Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy: A 10-Yr Cohort Study.

Journal: Transplantation and cellular therapy

Published: December 12, 2025

Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study.

Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study.

Journal: British journal of haematology

Published: November 20, 2025

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Journal: Cancer letters

Published: November 02, 2025

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.

Journal: Nature communications

Published: October 15, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026